These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1170 related articles for article (PubMed ID: 15515479)

  • 1. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
    Nasri H; Kheiri S
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of white blood cell count with left ventricular hypertrophy and ejection fraction in stable hemodialysis patients.
    Nasri H
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):31-6. PubMed ID: 17237888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum parathormone with hypertension in chronic renal failure patients treated with hemodialysis.
    Baradaran A; Nasri H
    Saudi J Kidney Dis Transpl; 2005; 16(3):288-92. PubMed ID: 17642794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
    Baradaran A; Nasri H
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
    Bradran A; Nasri H
    J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
    Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
    Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
    Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperthyroidism, therapy with erythropoietin, malnutrition and systolic function in hemodialysis: echocardiography study].
    Iannetti E; Carpinteri G; Vitale M; Squatrito R; Catalano D; Trovato GM
    Recenti Prog Med; 2000 Dec; 91(12):632-5. PubMed ID: 11194481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of myocardial remodeling in hemodialysis patients.
    Dimitrijevic Z; Cvetkovic T; Stojanovic M; Paunovic K; Djordjevic V
    Ren Fail; 2009; 31(8):662-7. PubMed ID: 19817519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukukda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
    J Nephrol; 2003; 16(5):641-9. PubMed ID: 14733409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
    Sakka Y; Babazono T; Sato A; Ujihara N; Iwamoto Y
    Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The comparison of selected parameters of structure and function of the cardiovascular system in patients with functioning graft on maintenance hemodialysis during a one year period].
    Króliczak M; Stompór T; Sułowicz W; Ochmański W; Królczyk J
    Przegl Lek; 2001; 58(10):894-902. PubMed ID: 11957815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.